Atorvastatin increases endoglin, SMAD2, phospohorylated SMAD2/3 and eNOS expression in ApoE/LDLR double knockout mice
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F09%3A00208924" target="_blank" >RIV/00216208:11150/09:00208924 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11160/09:00210110
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Atorvastatin increases endoglin, SMAD2, phospohorylated SMAD2/3 and eNOS expression in ApoE/LDLR double knockout mice
Original language description
In this study we aimed to elucidate whether endoglin is co-expressed with SMAD2, phospohorylated SMAD2/3 and eNOS in vivo in atherosclerotic lesions in ApoE/LDLR double knockout mice, and whether the expression of this proteins is affected by atorvastatin treatment.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FR - Pharmacology and apothecary chemistry
OECD FORD branch
—
Result continuities
Project
—
Continuities
S - Specificky vyzkum na vysokych skolach
Others
Publication year
2009
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Atherosclerosis and Thrombosis
ISSN
1340-3478
e-ISSN
—
Volume of the periodical
16
Issue of the periodical within the volume
3
Country of publishing house
JP - JAPAN
Number of pages
10
Pages from-to
—
UT code for WoS article
000267714200015
EID of the result in the Scopus database
—